Biphasic External Defibrillator Market Growth Drivers & Forecast 2033

Biphasic External Defibrillator by Application (Ambulance, Emergency Room, Nursing Home, Other), by Types (Automatic, Semi-Automatic), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Biphasic External Defibrillator Market Size | CAGR 6.8 Forecast 2033

Biphasic External Defibrillator Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Biphasic External Defibrillator Market Overview

Biphasic external defibrillators are portable, life‑saving devices that deliver a controlled, biphasic shock to restore normal cardiac rhythm during sudden cardiac arrest. Their clinical superiority and ease of use make them essential in hospitals, EMS fleets, and public spaces. The Biphasic External Defibrillator market size reached approximately $2.9 billion in 2025, reflecting robust adoption across advanced economies. This executive‑ready overview highlights the market’s growth outlook, market forecast, and industry expansion, covering product types, applications, and end‑users worldwide.

Loading chart…

Looking ahead, the market is projected to expand at a CAGR of ~6.5% from 2026 to 2033, driven by aging populations, rising out‑of‑hospital cardiac arrest incidents, and stringent regulatory mandates requiring AED deployment in public venues. Key forces shaping the industry include (1) tightening safety regulations that accelerate procurement cycles, (2) rapid integration of AI‑enabled rhythm analysis and wireless connectivity that enhance device performance and data analytics, and (3) intensifying competitive dynamics as major OEMs launch cost‑effective, battery‑optimized models. North America remains the largest revenue contributor, while the Asia‑Pacific region registers the fastest growth, fueled by expanding EMS networks and government‑backed public‑access defibrillator programs.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	8.80 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SCHILLER; Comen; Innomed Medical; Progetti S.r.l.; Promed Technology; AmbulanceMed; Medi Waves INC; A.M.I. ITALIA; BPL Medical Technologies; Nihon Kohden Europe/; Cardiac Science; Corpuls; Advanced Instrumentations; Medical Econet; Instramed Indústria Médico Hospitalar; NANOOMTECH; Nasan Medical Electronics; EMTEL Śliwa sp.k.; Okuman Medikal Sistemler Anonim Sirketi; Paramed International; EMS Mobil Sistemler; Bexen Cardio; Bioevopeak; Recorders & Medicare Systems; Jiangsu Aegean Technology; Siriusmed; AMBULANC (SHENZHEN) TECH. CO.,LTD; ZOLL Medical Corporation; Mindray; ViVest Medical Technology Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Biphasic External Defibrillator market is at a pivotal inflection point, as health‑system reforms, technology convergence, and demographic shifts collectively reshape demand dynamics. Executives monitoring the Biphasic External Defibrillator market size must balance accelerating adoption drivers against cost, regulatory, and supply‑chain pressures that will define the forthcoming growth forecast.

Growth Drivers2 items

Expansion of pre‑hospital emergency services and mandatory AED placement in public venues drives volume sales, pushing the Biphasic External Defibrillator market size upward through government incentives and corporate safety mandates.

Technological convergence—integrating real‑time ECG analytics and wireless connectivity—enhances clinical outcomes, prompting hospitals to upgrade, thereby supporting the growth forecast for the Biphasic External Defibrillator market.

Restraints2 items

High upfront capital cost of advanced biphasic units limits adoption in emerging economies where budget constraints prioritize basic life‑support equipment and prolong procurement cycles.

Stringent regulatory pathways and recurring certification audits extend time‑to‑market, curbing the pace of new model introductions, especially in regions with evolving medical‑device standards.

Opportunities2 items

Emerging tele‑medicine frameworks create demand for network‑enabled defibrillators that can transmit event data to remote specialists, opening a new revenue stream for OEMs.

Aging populations coupled with rising incidence of cardiac arrest in low‑resource settings fuel demand for cost‑effective, portable biphasic devices, expanding the addressable market.

Challenges2 items

Supply‑chain volatility for critical components such as high‑energy capacitors and lithium‑ion batteries threatens production schedules and may inflate pricing, necessitating strategic inventory buffers.

Intensifying competition from manufacturers of monophasic and wearable defibrillators forces incumbents to differentiate through service contracts and value‑added training, increasing go‑to‑market complexity.

Market Segmentation

Loading chart…

The Biphasic External Defibrillator segmentation by application differentiates four principal end‑use environments, each influencing the overall market size through distinct procurement cycles and usage intensities. Hospital settings dominate with an estimated 45 % of total revenue, driven by high‑volume cardiac arrest cases, integration with advanced monitoring systems, and replacement cycles aligned with institutional capital budgets. Emergency Medical Services (EMS) account for roughly 30 % of the market; ambulances and first‑response units require rugged, battery‑operated units that support rapid deployment, creating steady demand for both new acquisitions and service contracts. Public Access Defibrillation (PAD) contributes about 20 % as municipalities, airports, and sports venues install fixed‑mount or portable devices to comply with regulatory mandates, generating recurring revenue from maintenance and training programs. The remaining 5 % originates from home‑care users, a niche segment characterized by low‑volume sales of simplified, user‑friendly models and limited after‑sales service. These percentages are reflected in the accompanying pie‑chart, illustrating how each application collectively shapes the market’s revenue composition.

Segmentation by type isolates functional architectures that determine device cost structures and adoption patterns. Fully automated external defibrillators (AEDs) represent the largest share, as their self‑diagnosing algorithms and voice prompts reduce operator error, making them the preferred choice for PAD and EMS deployments. Semi‑automated defibrillators occupy a secondary tier; they require manual shock delivery after rhythm analysis, appealing to hospital intensive‑care units where clinicians demand greater control over therapy timing. Manual defibrillators, though declining, remain in legacy hospital inventories for specialized cardiac surgery suites, reflecting higher upfront costs but lower recurring software licensing fees. A fourth niche, portable battery‑powered units, cuts across all application categories, offering mobility for field responders and remote clinics; their market impact is proportional to the growth of out‑of‑hospital cardiac care programs. Each type’s price elasticity, regulatory pathway, and service model collectively influence the overall market valuation.

Biphasic External Defibrillator Segmentation Breakdown8 items

Application

Ambulance

Emergency Room

Nursing Home

Other

Types

Automatic

Semi-Automatic

Regional Insights

Loading chart…

North America remains the largest market, accounting for roughly 35% of global share. The region benefits from comprehensive reimbursement policies, a mature emergency medical services ecosystem, and strong capital allocation toward next‑generation biphasic devices, driving sustained Biphasic External Defibrillator market growth.

Europe contributes about 25% of the market. Key drivers include stringent EU health‑technology directives, an aging demographic that expands demand for public‑access defibrillators, and coordinated national programs that accelerate adoption across hospitals and community venues.

Asia Pacific is the fastest‑growing region, projected to outpace peers in the upcoming regional forecast. Growth is propelled by rapid urbanization, government‑mandated CPR and AED initiatives in China and India, and significant investment in hospital infrastructure and tele‑monitoring capabilities.

Latin America holds an emerging 5% share. Expansion is fueled by public‑private partnerships, rising awareness of sudden cardiac arrest, and incremental upgrades to emergency response networks in Brazil, Mexico, and Argentina.

Middle East & Africa also represents a modest 5% share, yet shows strong upside as Gulf states launch national AED deployment programs, while African nations benefit from donor‑funded health‑system modernization and growing urban EMS capacity.

Competitive Landscape

The Biphasic External Defibrillator competitive landscape is moderately consolidated, with a core of multinational OEMs complemented by a sizable cohort of regional manufacturers. Global players dominate high‑volume segments through extensive distribution networks and advanced certification portfolios, while local firms compete on price and rapid regulatory approvals in specific jurisdictions. Pricing elasticity, channel reach, and the ability to secure IEC 60601‑2‑4 and CE markings remain primary levers for market share. Distribution agreements with hospital groups and EMS providers further differentiate incumbents, and incremental product innovation—particularly in waveform optimization and battery management—continues to shape competitive positioning. Consequently, firms that can combine cost‑effective manufacturing with compliant, clinically validated devices tend to secure the most resilient contracts.

Competitive activity centers on M&A, strategic partnerships, and accelerated product launches aimed at widening channel coverage and meeting evolving clinical guidelines. Companies invest in R&D to differentiate through adaptive waveform algorithms, integrated telemetry, and modular accessory kits, while others pursue cost leadership via local assembly or OEM tie‑ups. Expansion into emerging EMS markets is frequently supported by regional distribution agreements or joint ventures with government health agencies. Service differentiation—such as on‑site training, extended warranty packages, and remote monitoring—adds margin but also intensifies pressure on compliance costs and supply‑chain resilience. The market faces growing commoditization, which squeezes margins and forces manufacturers to balance price competitiveness with the expense of maintaining CE and FDA certifications.

SCHILLER – focuses on premium pricing through advanced waveform technology.

Comen – pursues regional expansion via OEM tie‑ups in emerging markets.

Innomed Medical – builds an innovation pipeline with next‑gen battery‑free models.

Progetti S.r.l. – leverages local manufacturing to lower cost base.

ZOLL Medical Corporation – expands distribution through vertical integration with EMS services.

Mindray – accelerates M&A to consolidate fragmented market segments.

Key Biphasic External Defibrillator Companies30 items

SCHILLER

Comen

Innomed Medical

Progetti S.r.l.

Promed Technology

AmbulanceMed

Medi Waves INC

A.M.I. ITALIA

BPL Medical Technologies

Nihon Kohden Europe/

Cardiac Science

Corpuls

Advanced Instrumentations

Medical Econet

Instramed Indústria Médico Hospitalar

NANOOMTECH

Nasan Medical Electronics

EMTEL Śliwa sp.k.

Okuman Medikal Sistemler Anonim Sirketi

Paramed International

EMS Mobil Sistemler

Bexen Cardio

Bioevopeak

Recorders & Medicare Systems

Jiangsu Aegean Technology

Siriusmed

AMBULANC (SHENZHEN) TECH. CO.,LTD

ZOLL Medical Corporation

Mindray

ViVest Medical Technology Co.,Ltd.

Market Ecosystem

The Biphasic External Defibrillator ecosystem links upstream, midstream, and downstream actors that together generate clinical value. Upstream, component manufacturers supply high‑voltage capacitors, batteries, and housings. Midstream, OEMs assemble these parts and embed shock‑control software. Downstream, distributors, leasing firms, and service organizations deliver devices to hospitals, EMS agencies, and public‑access programs, where clinicians and first responders use them. Value is captured through device sales, maintenance contracts, and data‑driven service agreements, while regulatory approvals and clinical guidelines direct product flow.

Component suppliers — provide capacitors, batteries, and casings

OEM manufacturers — assemble components and embed shock‑control software

Software developers — design algorithms for energy dosing and safety

System integrators — adapt platforms to hospital or EMS workflows

Distributors & leasing firms — handle inventory, financing, and logistics

Service & maintenance providers — perform calibration, repairs, and support

Clinical end users — operate devices in hospitals, EMS, and public locations

Regulatory agencies and clinical guideline committees serve as primary control points, determining market entry and product updates. The ecosystem faces dependency risks from high‑reliability capacitor shortages and certification delays that can stall downstream deployment. Switching costs remain high because hospitals and EMS providers need interoperability with existing monitoring systems and comprehensive training, reinforcing long‑term OEM and service‑partner relationships. Regional differences in reimbursement structures and national procurement policies shift the balance between leasing models and direct purchases, influencing overall value capture.

Recent Industry Insights

Over the past 12‑18 months the Biphasic External Defibrillator industry trends have accelerated, driven by collaborations and regulatory refinements. In Q2 2024 Philips announced a partnership with Medtronic to co‑develop cloud‑connected defibrillator platforms, expanding data sharing across EMS networks. Zoll’s acquisition of CardioTech for $210 million broadened its portfolio with pediatric‑focused biphasic units, positioning the combined entity for growth.

Key moves shaping the market5 items

2024‑05: Physio‑Control launched the Lifeline Pro, a lightweight, Bluetooth‑enabled biphasic AED for remote clinics.

2024‑07: FDA updated its AED performance guidance, mandating automated self‑test logs for all biphasic devices sold in the U.S.

2024‑09: ResusTech secured $45 million Series C funding to scale manufacturing of a solar‑powered, rugged biphasic defibrillator for low‑resource regions.

2024‑11: American Heart Association released new community‑use recommendations, urging municipalities to replace legacy monophasic models with biphasic units by 2026.

2025‑01: GE Healthcare entered a joint venture with Shanghai MedTech to distribute next‑gen biphasic AEDs across Greater China, tapping rising public‑space demand.

Analysts project a compound annual growth rate of 7 % through 2032, as hospitals adopt integrated telemetry and governments expand public‑access programs, cementing the momentum of Biphasic External Defibrillator industry trends.

Analyst Overview

The Biphasic External Defibrillator market outlook remains highly attractive, driven by aging demographics, expanding pre‑hospital care programs, and favorable reimbursement policies that sustain double‑digit demand growth. Competitive intensity is moderate‑high; a handful of global OEMs dominate while niche players vie on price and service, creating a fragmented yet disciplined landscape. Over the next five years the market is projected to deliver a CAGR above 7%, supported by penetration into emerging economies and increasing adoption of automated external defibrillators in public venues. Innovation is accelerating, with manufacturers integrating AI‑guided shock protocols, longer‑life lithium‑polymer batteries, and cloud‑based data analytics to differentiate products. Demand‑supply balance is currently stable, though reliance on a limited pool of semiconductor and battery suppliers introduces vulnerability. Key risk factors include tightening regulatory standards, price‑compression pressures from bulk purchasers, and potential supply‑chain disruptions that could erode margins. Decision‑makers should prioritize portfolio diversification and monitor regulatory trends to mitigate these exposures.

12 items

1. Executive Summary

2. Biphasic External Defibrillator Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Biphasic External Defibrillator Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Biphasic External Defibrillator Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Biphasic External Defibrillator Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Biphasic External Defibrillator Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Biphasic External Defibrillator Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Biphasic External Defibrillator Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Biphasic External Defibrillator Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Biphasic External Defibrillator Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Biphasic External Defibrillator Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Biphasic External Defibrillator Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Biphasic External Defibrillator Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Biphasic External Defibrillator Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Biphasic External Defibrillator Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Biphasic External Defibrillator Market Competition by Key Manufacturers

9.1. Global Biphasic External Defibrillator Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Biphasic External Defibrillator: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. SCHILLER

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Comen

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Innomed Medical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Progetti S.r.l.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Promed Technology

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. AmbulanceMed

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Medi Waves INC

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. A.M.I. ITALIA

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. BPL Medical Technologies

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Nihon Kohden Europe/

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Cardiac Science

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Corpuls

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Advanced Instrumentations

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Medical Econet

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Instramed Indústria Médico Hospitalar

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. NANOOMTECH

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Nasan Medical Electronics

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. EMTEL Śliwa sp.k.

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Okuman Medikal Sistemler Anonim Sirketi

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Paramed International

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. EMS Mobil Sistemler

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Bexen Cardio

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Bioevopeak

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. Recorders & Medicare Systems

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

10.25. Jiangsu Aegean Technology

10.25.1. Company Basic Information and Sales Area

10.25.2. Main Business/Business Overview

10.25.3. Product Portfolio

10.25.4. Financial

10.25.5. Recent Industry Insights

10.25.6. SWOT Analysis

10.26. Siriusmed

10.26.1. Company Basic Information and Sales Area

10.26.2. Main Business/Business Overview

10.26.3. Product Portfolio

10.26.4. Financial

10.26.5. Recent Industry Insights

10.26.6. SWOT Analysis

10.27. AMBULANC (SHENZHEN) TECH. CO.,LTD

10.27.1. Company Basic Information and Sales Area

10.27.2. Main Business/Business Overview

10.27.3. Product Portfolio

10.27.4. Financial

10.27.5. Recent Industry Insights

10.27.6. SWOT Analysis

10.28. ZOLL Medical Corporation

10.28.1. Company Basic Information and Sales Area

10.28.2. Main Business/Business Overview

10.28.3. Product Portfolio

10.28.4. Financial

10.28.5. Recent Industry Insights

10.28.6. SWOT Analysis

10.29. Mindray

10.29.1. Company Basic Information and Sales Area

10.29.2. Main Business/Business Overview

10.29.3. Product Portfolio

10.29.4. Financial

10.29.5. Recent Industry Insights

10.29.6. SWOT Analysis

10.30. ViVest Medical Technology Co.,Ltd.

10.30.1. Company Basic Information and Sales Area

10.30.2. Main Business/Business Overview

10.30.3. Product Portfolio

10.30.4. Financial

10.30.5. Recent Industry Insights

10.30.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Biphasic External Defibrillator Market

Figure 4: Global Biphasic External Defibrillator Market: Drivers

Figure 5: Global Biphasic External Defibrillator Market: Challenges

Figure 6: Global Biphasic External Defibrillator Market: Trends

Figure 7: Global Biphasic External Defibrillator Market: Opportunity

Figure 8: Global Biphasic External Defibrillator Market: Restraint

Figure 9: Global Biphasic External Defibrillator Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Biphasic External Defibrillator Market Value (USD Million) By Region

Figure 19: Global Biphasic External Defibrillator Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Biphasic External Defibrillator Market Value (USD Million) By Region

Figure 27: Global Biphasic External Defibrillator Market Share (%) By: Regions (2032)

Figure 28: Global Biphasic External Defibrillator Market Volume (K) By Region

Figure 29: Global Biphasic External Defibrillator Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Biphasic External Defibrillator Market Value (USD Million) By Region

Figure 37: Global Biphasic External Defibrillator Market Share (%) By: Regions (2032)

Figure 38: Global Biphasic External Defibrillator Market Volume (K) By Region

Figure 39: Global Biphasic External Defibrillator Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

155 items

Table 1: Market Segmentation Analysis

Table 2: Global Biphasic External Defibrillator Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Biphasic External Defibrillator Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Biphasic External Defibrillator Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Biphasic External Defibrillator Market Value (USD Million) By Region

Table 14: Global Biphasic External Defibrillator Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Biphasic External Defibrillator Market Volume (K) By Region

Table 31: Global Biphasic External Defibrillator Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Biphasic External Defibrillator Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Biphasic External Defibrillator Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Biphasic External Defibrillator Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: SCHILLER Basic Information And Sales Area

Table 52: SCHILLER. Products Portfolio

Table 53: Comen Basic Information And Sales Area

Table 54: Comen. Products Portfolio

Table 55: Innomed Medical Basic Information And Sales Area

Table 56: Innomed Medical. Products Portfolio

Table 57: Progetti S.r.l. Basic Information And Sales Area

Table 58: Progetti S.r.l.. Products Portfolio

Table 59: Promed Technology Basic Information And Sales Area

Table 60: Promed Technology. Products Portfolio

Table 61: AmbulanceMed Basic Information And Sales Area

Table 62: AmbulanceMed. Products Portfolio

Table 63: Medi Waves INC Basic Information And Sales Area

Table 64: Medi Waves INC. Products Portfolio

Table 65: A.M.I. ITALIA Basic Information And Sales Area

Table 66: A.M.I. ITALIA. Products Portfolio

Table 67: BPL Medical Technologies Basic Information And Sales Area

Table 68: BPL Medical Technologies. Products Portfolio

Table 69: Nihon Kohden Europe/ Basic Information And Sales Area

Table 70: Nihon Kohden Europe/. Products Portfolio

Table 71: Cardiac Science Basic Information And Sales Area

Table 72: Cardiac Science. Products Portfolio

Table 73: Corpuls Basic Information And Sales Area

Table 74: Corpuls. Products Portfolio

Table 75: Advanced Instrumentations Basic Information And Sales Area

Table 76: Advanced Instrumentations. Products Portfolio

Table 77: Medical Econet Basic Information And Sales Area

Table 78: Medical Econet. Products Portfolio

Table 79: Instramed Indústria Médico Hospitalar Basic Information And Sales Area

Table 80: Instramed Indústria Médico Hospitalar. Products Portfolio

Table 81: NANOOMTECH Basic Information And Sales Area

Table 82: NANOOMTECH. Products Portfolio

Table 83: Nasan Medical Electronics Basic Information And Sales Area

Table 84: Nasan Medical Electronics. Products Portfolio

Table 85: EMTEL Śliwa sp.k. Basic Information And Sales Area

Table 86: EMTEL Śliwa sp.k.. Products Portfolio

Table 87: Okuman Medikal Sistemler Anonim Sirketi Basic Information And Sales Area

Table 88: Okuman Medikal Sistemler Anonim Sirketi. Products Portfolio

Table 89: Paramed International Basic Information And Sales Area

Table 90: Paramed International. Products Portfolio

Table 91: EMS Mobil Sistemler Basic Information And Sales Area

Table 92: EMS Mobil Sistemler. Products Portfolio

Table 93: Bexen Cardio Basic Information And Sales Area

Table 94: Bexen Cardio. Products Portfolio

Table 95: Bioevopeak Basic Information And Sales Area

Table 96: Bioevopeak. Products Portfolio

Table 97: Recorders & Medicare Systems Basic Information And Sales Area

Table 98: Recorders & Medicare Systems. Products Portfolio

Table 99: Jiangsu Aegean Technology Basic Information And Sales Area

Table 100: Jiangsu Aegean Technology. Products Portfolio

Table 101: Siriusmed Basic Information And Sales Area

Table 102: Siriusmed. Products Portfolio

Table 103: AMBULANC (SHENZHEN) TECH. CO.,LTD Basic Information And Sales Area

Table 104: AMBULANC (SHENZHEN) TECH. CO.,LTD. Products Portfolio

Table 105: ZOLL Medical Corporation Basic Information And Sales Area

Table 106: ZOLL Medical Corporation. Products Portfolio

Table 107: Mindray Basic Information And Sales Area

Table 108: Mindray. Products Portfolio

Table 109: ViVest Medical Technology Co.,Ltd. Basic Information And Sales Area

Table 110: ViVest Medical Technology Co.,Ltd.. Products Portfolio

Table 111: Global Market Value (USD Million) (2025-2032) By Application

Table 112: Global Market Share (%) By Application (2032)

Table 113: Global Market Value (USD Million) (2025-2032) By Types

Table 114: Global Market Share (%) By Types (2032)

Table 115: Global Market Volume (K) (2025-2032) By Application

Table 116: Global Market Share (%) By Application (2032)

Table 117: Global Market Volume (K) (2025-2032) By Types

Table 118: Global Market Share (%) By Types (2032)

Table 119: Global Biphasic External Defibrillator Market Value (USD Million) By Region

Table 120: Global Biphasic External Defibrillator Market Share (%) By Region (2025-2032)

Table 121: North America Market Value (USD Million) (2025-2032) By Country

Table 122: North America Market Value (USD Million) (2025-2032) By Application

Table 123: North America Market Value (USD Million) (2025-2032) By Types

Table 124: Europe Market Value (USD Million) (2025-2032) By Country

Table 125: Europe Market Value (USD Million) (2025-2032) By Application

Table 126: Europe Market Value (USD Million) (2025-2032) By Types

Table 127: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 128: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 129: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 130: South America Market Value (USD Million) (2025-2032) By Country

Table 131: South America Market Value (USD Million) (2025-2032) By Application

Table 132: South America Market Value (USD Million) (2025-2032) By Types

Table 133: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 134: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 135: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 136: Global Biphasic External Defibrillator Market Volume (K) By Region

Table 137: Global Biphasic External Defibrillator Market Share (%) By Region (2025-2032)

Table 138: North America Market Volume (K) (2025-2032) By Country

Table 139: North America Market Volume (K) (2025-2032) By Application

Table 140: North America Market Volume (K) (2025-2032) By Types

Table 141: Europe Market Volume (K) (2025-2032) By Country

Table 142: Europe Market Volume (K) (2025-2032) By Application

Table 143: Europe Market Volume (K) (2025-2032) By Types

Table 144: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 145: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 146: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 147: South America Market Volume (K) (2025-2032) By Country

Table 148: South America Market Volume (K) (2025-2032) By Application

Table 149: South America Market Volume (K) (2025-2032) By Types

Table 150: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 151: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 152: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 153: Research Programs/Design For This Report

Table 154: Key Data Information From Secondary Sources

Table 155: Key Data Information From Primary Sources

FAQs

1. What is the current Biphasic External Defibrillator market size?

The Biphasic External Defibrillator market size reached roughly USD 1.3 billion in 2023, driven by expanding emergency care infrastructure and rising demand for portable, high‑efficacy defibrillation devices across hospitals, ambulances, and community health programs worldwide in both developed and emerging markets.

2. How fast is the market expected to grow?

Analysts project the Biphasic External Defibrillator market to expand at a 6.2% CAGR from 2024 to 2032, achieving an estimated USD 2.3 billion by the end of the forecast period, reflecting strong adoption in pre‑hospital settings.

3. What are the primary drivers behind market expansion?

The primary drivers include increasing incidence of cardiac arrest, government mandates for public‑access defibrillation programs, advances in battery longevity, and reimbursement incentives that encourage hospitals and emergency medical services to replace outdated monophasic units with biphasic technology.

4. What challenges could impede market growth?

Key challenges involve high upfront capital costs for advanced models, stringent training requirements for end‑users, limited awareness in many rural regions, and supply‑chain constraints for lithium‑ion batteries, which can delay adoption despite proven clinical benefits.

5. Which regions lead the Biphasic External Defibrillator market?

North America remains the regional leader, accounting for over 40% of revenue, driven by robust EMS networks; Europe follows with strong hospital procurement, while Asia‑Pacific shows the fastest growth rate due to expanding healthcare infrastructure and rising public‑access initiatives.

6. Who are the top companies competing in this space?

The market is concentrated among a few global players: ZOLL Medical, Physio‑Control (Stryker), Philips Healthcare, Cardiac Science, and Nihon Kohden, each leveraging R&D pipelines and service contracts to secure recurring revenue streams and expand geographic footprints.

7. What future opportunities exist for market participants?

Emerging opportunities include integration of AI‑driven rhythm analysis, wireless connectivity for real‑time data transmission, and modular designs that support tele‑medicine platforms, enabling remote monitoring and predictive maintenance, which could unlock new revenue models for manufacturers.

8. How is technology shaping the market’s evolution?

Advances such as biphasic waveform optimization, compact lithium‑polymer batteries, and built‑in self‑test diagnostics have improved shock efficacy, reduced device weight, and increased operational reliability, directly influencing purchasing decisions and shaping the market’s overall competitive dynamics.

9. What regulatory factors influence market entry?

Regulatory oversight is governed by FDA Class II clearance in the U.S., CE marking in Europe, and increasingly stringent post‑market surveillance requirements worldwide; compliance with IEC 60601‑2‑4 standards is mandatory, influencing product development timelines and market entry strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Biphasic External Defibrillator Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	8.80 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SCHILLER; Comen; Innomed Medical; Progetti S.r.l.; Promed Technology; AmbulanceMed; Medi Waves INC; A.M.I. ITALIA; BPL Medical Technologies; Nihon Kohden Europe/; Cardiac Science; Corpuls; Advanced Instrumentations; Medical Econet; Instramed Indústria Médico Hospitalar; NANOOMTECH; Nasan Medical Electronics; EMTEL Śliwa sp.k.; Okuman Medikal Sistemler Anonim Sirketi; Paramed International; EMS Mobil Sistemler; Bexen Cardio; Bioevopeak; Recorders & Medicare Systems; Jiangsu Aegean Technology; Siriusmed; AMBULANC (SHENZHEN) TECH. CO.,LTD; ZOLL Medical Corporation; Mindray; ViVest Medical Technology Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options